Bivalirudin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Bivalirudin
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Bivalirudin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 14 USDMF, 1 EU WC, 11 NDC API, 15 Listed Suppliers, $ API Reference Price

24 API Suppliers
14 USDMF
1 EU WC
11 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

32 FDF Dossiers, 17 FDA Orange Book, 5 Europe, 4 Canada, 2 Australia, 4 Listed Dossiers

32 FDF Dossiers
17 FDA Orange Book
5 Europe
4 Canada
2 Australia
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 250MG/50ML (5MG/ML), SOLUTION;INTRAVENOUS - 500MG/100ML (5MG/ML), INJECTABLE;INTRAVENOUS - 250MG/VIAL

SOLUTION;INTRAVENOUS - 250MG/50ML (5MG/ML)
SOLUTION;INTRAVENOUS - 500MG/100ML (5MG/ML)
INJECTABLE;INTRAVENOUS - 250MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
1 Faran Shimi Pharmaceutical
1 Pfanstiehl
3 Actylis
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 9 Direct Compression, 9 Taste Masking, 7 Parenteral, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Granulation, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
9 Direct Compression
9 Taste Masking
7 Parenteral
4 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
3 Granulation
1 API Stability Enhancers
1 Thickeners and Stabilizers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 21 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Finished Drug Prices

3 Finished Drug Prices

MARKET PLACE

5 APIs, 1 FDF Dossiers

5 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 1 Health Canada Patents

7 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

$ API Ref.Price (USD/KG) : 101,028 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Sandoz Canada Inc.

filter Patent Reset all filters

1 All

01 12623449

filter Product Reset all filters

1 All

01 1Bivalirudin

filter Dosage Reset all filters

1 All

01 1Powder for solution

filter Exp Date Reset all filters

1 All

01 12028-03-27

Bachem Bivalirudin

Product Main Page

01

Sandoz Canada Inc.

Bivalirudin

Antibody Engineering

Not Confirmed

Sandoz Canada Inc.

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-27

Date Granted : 2010-11-02

Bivalirudin

Brand Name : ANGIOMAX

Patent Number : 2623449

Filing Date : 2008-03-27

Strength per Unit : 250 mg / vial

Dosage Form : Powder for solution

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2028-03-27

Date Granted : 2010-11-02

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?